Geode Capital Management
HPTX

Geode Capital Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Geode Capital Management’s Portfolio HPTX Stock Details HPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-99,730
Closed -$4.58M – 4038
2015
Q1 		$4.58M Buy
99,730
+9,637
+11% +$288K ﹤0.01% 1905
2014
Q4 		$2.16M Buy
90,093
+22,605
+33% +$510K ﹤0.01% 2378
2014
Q3 		$1.7M Buy
67,488
+23,085
+52% +$573K ﹤0.01% 2455
2014
Q2 		$1.16M Buy
44,403
+10,152
+30% +$261K ﹤0.01% 2712
2014
Q1 		$883K Buy
34,251
+896
+3% +$24.3K ﹤0.01% 2863
2013
Q4 		$674K Buy
33,355
+2,053
+7% +$48.3K ﹤0.01% 2934
2013
Q3 		$818K Buy
31,302
+2,300
+8% +$57.6K ﹤0.01% 2705
2013
Q2 		$638K Buy
+29,002
New +$635K ﹤0.01% 2734

Geode Capital Management's HPTX Position: Q2 2015 in Review

Geode Capital Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 99,730 shares — an estimated $4.58M sold.

Geode Capital Management first reported a position in HPTX in Q2 2013 and held it in 8 quarters. The position peaked at $4.58M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

  • Geode Capital Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Geode Capital Management sold 99,730 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $4.58M.
  • Geode Capital Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • Geode Capital Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $4.58M in Q1 2015.
  • 0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Geode Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.